Amgen Shadow Pricing Of Enbrel Under Scrutiny At US House Hearing

 
• By Jessica Merrill
  
Shadow
US Congress took issue with industry "shadow pricing" • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access